HCPCS Level IIdrugActive
J2251
Inj midazolam in 0.9% nacl
BETOS: O1E
Effective: 2024-10-01
Description
Injection, midazolam in 0.9% sodium chloride, intravenous, not therapeutically equivalent to j2250, 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Midazolam HCl
Manufacturer
Hikma Pharmaceuticals USA Inc.
HCPCS Dosage
1 MG
Billing Units
50.0000
8
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.